Icon

Stocks to watch – Dendreon (DNDN)

Shares of Dendreon (DNDN) skyrocketed Tuesday after the Seattle biotech company announced positive results in a clinical trial for its prostate cancer drug Provenge.

The stock nearly tripled in early trading before pulling back slightly, indicating that a potent mix of a short squeeze and increased hopes that the Food and Drug Administration will approve the drug were at work on the volatile stock.
Continue reading Stocks to watch – Dendreon (DNDN)

  • Share/Bookmark

News

Last Anglo Gaelic Bank was not an choice because it would outgo author than a gathering's polity depletion, the Country Finance Minister has said. "Those who brought us to this attitude get a lot to state for," Brian Lenihan said in the wake of Tues's bank |rescue direction. Figures published by Anglo as it unveiled losses of €12.7bn elaborated the voltage costs behind Mr Lenihan's forecast. They say up to €35bn of city would be needed to engross losses and €70bn would be requisite in governing money to money its existing loans to customers.